Can a smartphone app ease social anxiety in teens and young adults?
NCT ID NCT06490315
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a mobile app called OkeyMind can reduce social anxiety and depression in young people aged 15 to 24. The app provides psychoeducation and guided meditation over one month. 180 participants will be randomly assigned to use the app immediately or wait three months. Researchers will measure changes in anxiety, depression, and quality of life at one and three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mobile psychoeducation program (OkeyMind) with meditation
- What this could lead to
- If it works, this could offer a low-cost, accessible way to reduce social anxiety and depression in young people, especially where mental health resources are scarce.
- What could go wrong
- This is a relatively small trial (180 people) testing a short-term app-based program. The effects may be modest, and long-term benefits are unknown. No serious risks are expected, but the app may not help everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hong Kong Shue Yan University
Hong Kong, Hong Kong, HKG, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers